If you are one of our readers who is really “into” the underlying causes of and development of prostate cancer, then you probably want to see if you can read a newly published article in this week’s New England Journal of Medicine. … READ MORE …
Filed under: Uncategorized | Tagged: epigenetics, evolution, genetrics, initiation, progression | 2 Comments »
According to an hypothesis just published by a group of researchers at the Dana-Farber Cancer Institute in Boston, they have identified “a new epigenetic program occurring as you transition from normal to tumor cells” in the development of prostate cancer. … READ MORE …
Filed under: Risk | Tagged: cancer, development, epigenetics, gene, programming, prostate | Leave a comment »
According to an article published in Science on Friday last week, activation of an epigenetic regulator known as EZH2 (“enhancer of zeste homolog 2”) may be critical to the onset and progression of castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer | Tagged: castration-resistant, CRPC, epigenetics, EZH2 | Leave a comment »
We have commented before on the potential of epigenetics in the development of innovative therapies for the management of prostate cancer. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: drug development, epigenetics, epigenome, review, vorinostat | Leave a comment »
If you’ve been hoping that research in the field of epigenetics is going to bring us a cure for prostate cancer in the next few years, dream on! … READ MORE …
Filed under: Drugs in development | Tagged: drug development, epigenetics | 3 Comments »
Today’s prostate cancer news report summary includes items dealing with:
Filed under: Diagnosis, Management, Prevention, Risk, Treatment | Tagged: brachytherapy, EBRT, epigenetics, Gleason 3 + 4 4 + 3, lycopene, PBRT, proton beam, selenium, vitamin E | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 